DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCorporate Action

Jfl Life Sciences Limited — Appointment

NSE 26 Aug·26 Aug 2026, 5:28 pm

JFL Life Sciences

JFL Life Sciences Limited has announced the re-appointment of Mr. Smiral Ashwinkumar Patel as its Managing Director, effective January 18, 2027. This move extends his tenure at the helm of the company for another term.

For investors, this development signals continuity in the company's leadership. A stable management team is often viewed as a positive factor, as it can help maintain strategic direction and operational focus. The re-appointment suggests confidence from the board in Patel's ability to steer the company forward.

Investors should monitor the company's future quarterly results and strategic announcements under this renewed leadership. Keeping an eye on how the management executes its plans will be key to understanding the company's growth trajectory.